Plasma cytokines interleukin-18 and C-X-C motif chemokine ligand 10 are indicative of the anti-programmed cell death protein-1 treatment response in lung cancer patients

BACKGROUND: Although programmed cell death protein-1 (PD-1)/programmed death ligand-1 (PD-L1) checkpoint inhibitors have shown prominent efficacy for treatment of advanced lung cancer, the outcomes of metastatic lung cancer remain poor throughout the world. Although progression-free survival (PFS) a...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yida, Chen, Hanxiao, Zhang, Tianzhuo, Yang, Xue, Zhong, Jia, Wang, Yuyan, Chi, Yujia, Wu, Meina, An, Tongtong, Li, Jianjie, Zhao, Xinghui, Dong, Zhi, Wang, Ziping, Zhao, Jun, Zhuo, Minglei, Huang, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859784/
https://www.ncbi.nlm.nih.gov/pubmed/33553326
http://dx.doi.org/10.21037/atm-20-1513

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7859784/
https://www.ncbi.nlm.nih.gov/pubmed/33553326
http://dx.doi.org/10.21037/atm-20-1513

Ejemplares similares